Aziz Mottiwala, the Chief Commercial Officer of $TARS, sold 3,557 shares of the company on 03-19-2025 for an estimated $168,601. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.9% of their shares of this class of stock. Following this trade, they now own 68,422 shares of this class of $TARS stock.
$TARS Insider Trading Activity
$TARS insiders have traded $TARS stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $TARS stock by insiders over the last 6 months:
- BOBAK R. AZAMIAN (President/CEO and Board Chair) has made 0 purchases and 3 sales selling 24,216 shares for an estimated $1,163,050.
- AZIZ MOTTIWALA (Chief Commercial Officer) has made 0 purchases and 3 sales selling 10,565 shares for an estimated $505,856.
- BRYAN WAHL (General Counsel) has made 0 purchases and 3 sales selling 9,686 shares for an estimated $463,765.
- SESHADRI NEERVANNAN (Chief Operating Officer) has made 0 purchases and 3 sales selling 7,583 shares for an estimated $363,141.
- DIANNE C. WHITFIELD (Chief Human Resources Officer) has made 0 purchases and 3 sales selling 6,711 shares for an estimated $321,323.
- JEFFREY S FARROW (See Remarks) has made 0 purchases and 3 sales selling 3,724 shares for an estimated $178,306.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TARS Hedge Fund Activity
We have seen 108 institutional investors add shares of $TARS stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TORONTO DOMINION BANK added 1,909,228 shares (+inf%) to their portfolio in Q4 2024, for an estimated $105,713,954
- PERCEPTIVE ADVISORS LLC removed 1,109,754 shares (-85.6%) from their portfolio in Q4 2024, for an estimated $61,447,078
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 883,043 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $48,894,090
- LORD, ABBETT & CO. LLC added 685,111 shares (+115.2%) to their portfolio in Q4 2024, for an estimated $37,934,596
- VIVO CAPITAL, LLC removed 565,550 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $18,600,939
- J. GOLDMAN & CO LP removed 427,305 shares (-76.6%) from their portfolio in Q4 2024, for an estimated $23,659,877
- IKARIAN CAPITAL, LLC removed 422,588 shares (-41.0%) from their portfolio in Q4 2024, for an estimated $23,398,697
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TARS Analyst Ratings
Wall Street analysts have issued reports on $TARS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 03/06/2025
- Barclays issued a "Overweight" rating on 01/27/2025
- Oppenheimer issued a "Outperform" rating on 01/22/2025
- Guggenheim issued a "Buy" rating on 11/29/2024
To track analyst ratings and price targets for $TARS, check out Quiver Quantitative's $TARS forecast page.
$TARS Price Targets
Multiple analysts have issued price targets for $TARS recently. We have seen 3 analysts offer price targets for $TARS in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- An analyst from Jefferies set a target price of $58.0 on 03/06/2025
- Balaji Prasad from Barclays set a target price of $62.0 on 01/27/2025
- Francois Brisebois from Oppenheimer set a target price of $72.0 on 01/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
